TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/24/2026
Back to search
Official data from USPTO
DV
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/26/2026
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
08/05/2022
Registration date
04/02/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/26/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/31/2022
First use in commerce
11/14/2022
Drawing code
4
Owner type
03
Owner location
Allentown, NJ, US
Examiner
DIBLE, JONATHON I
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SciMar ONE, Inc.
Representatives
Neil M. Barnes Neo IP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SAAS) services featuring software using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals; Platform as a service (PAAS) services featuring software platforms using artificial intelligence for use in pharmaceutical drug development, metadata tagging in the fields of healthcare and pharmaceuticals, identifying biomarkers, identifying mutations, identifying comorbidities, identifying side effects of drugs, identifying efficacy of drugs, identifying clinical study designs, identifying pharmacokinetics (PK), identifying study arms for clinical studies, identifying patient characteristics, identifying disease characteristics, identifying labs, identifying resistance markers, identifying disease therapies, vaccine development, diagnostics development in the fields of healthcare and pharmaceuticals, analyzing clinical data in the fields of healthcare and pharmaceuticals, analyzing clinical data in healthcare databases, health economics and outcomes research (HEOR) in the fields of healthcare and pharmaceuticals, conducting clinical trials in the fields of healthcare and pharmaceuticals, accessing and analyzing competitive intelligence information in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a drug and over the life of a drug, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals, personalizing treatment options in the fields of healthcare and pharmaceuticals, and patient identification in the fields of healthcare and pharmaceuticals
Publications
History of USPTO decisions and trademark events.
28 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/24/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/24/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/28/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/27/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/24/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/24/2024
IUAF
USE AMENDMENT FILED
02/01/2024
EISU
TEAS STATEMENT OF USE RECEIVED
02/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2023
GNRT
NON-FINAL ACTION E-MAILED
06/03/2023
CNRT
NON-FINAL ACTION WRITTEN
06/03/2023
DOCK
ASSIGNED TO EXAMINER
05/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2022
NWAP
NEW APPLICATION ENTERED
08/09/2022
Continuous trademark protection
Get notified about every new filing that threatens DV or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.